Mountain Crest Acquisition Corp. V (MCAGU) Financial Statements (2026 and earlier)

Company Profile

Business Address 524 BROADWAY
NEW YORK, NY 10012
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1211716259475
Cash and cash equivalent1211716259475
Prepaid expense2140 1197
Total current assets:3315716271572
Noncurrent Assets
Intangible asset, including goodwill, after accumulated amortization     
Intangible asset, excluding goodwill, after accumulated amortization     
Other undisclosed noncurrent assets8411,1575,613 69,001
Total noncurrent assets:8411,1575,613 69,001
Other undisclosed assets    19,572 
TOTAL ASSETS:8741,3145,62919,84369,573
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:27134858232098
Accrued liabilities81284295181 
Other undisclosed accounts payable and accrued liabilities1896428713998
Other undisclosed current liabilities1,3811,172695 7
Total current liabilities:1,6521,5211,277320105
Noncurrent Liabilities
Liabilities, other than long-term debt2,0702,070   
Deferred compensation liability, classified2,0702,070   
Other undisclosed noncurrent liabilities   2,070 2,070
Total noncurrent liabilities:2,0702,0702,070 2,070
Other undisclosed liabilities    2,251 
Total liabilities:3,7223,5913,3472,5712,175
Temporary equity, including noncontrolling interest8351,1645,57919,55069,000
Equity
Equity, attributable to parent(3,684)(3,440)(3,297)(2,278)(1,602)
Common stock00000
Additional paid in capital2,2182,2251,947  
Accumulated deficit(5,903)(5,666)(5,244)(2,278)(1,603)
Total equity:(3,684)(3,440)(3,297)(2,278)(1,602)
TOTAL LIABILITIES AND EQUITY:8741,3145,62919,84369,573

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenues
(Net Investment Income)		46265511932 
Gross profit:46265511932 
Operating expenses(472)(618)(2,655)(747) 
Other undisclosed operating loss(46)(265)(511)(932) 
Operating loss:(472)(618)(2,655)(747) 
Nonoperating income50290505932 
Investment income, nonoperating 27140129231 
Interest and debt expense  26(6)  
Income (loss) from continuing operations before equity method investments, income taxes:(422)(303)(2,155)185 
Other undisclosed income (loss) from continuing operations before income taxes  (26)6  
Income (loss) from continuing operations before income taxes:(422)(329)(2,150)185 
Income tax expense(9)(46)(101)(181) 
Net income (loss) available to common stockholders, diluted:(431)(374)(2,251)4 

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Net income (loss):(431)(374)(2,251)4 
Comprehensive income (loss), net of tax, attributable to parent:(431)(374)(2,251)4 

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: